ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tumors and lymphoma models with BRAF and RAS mutations and also in a melanoma PDX model resistant to BRAF and MEK inhibitors.
仅供研究使用。 我们不向患者出售。
名称 | ASN007 |
---|---|
Iupac 化学名称 | (S)-N-(2-amino-1-(3-chloro-5-fluorophenyl)ethyl)-1-(5-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1H-imidazole-4-carboxamide |
同义词 | ASN007; ASN-007; ASN 007; |
英文同义词 | ASN007; ASN-007; ASN 007; |
分子式 | C22H25ClFN7O2 |
分子量 | 473.9374 |
Smile | CC1=CN=C(NC2CCOCC2)N=C1N3C=NC(C(N[C@H](CN)C4=CC(F)=CC(Cl)=C4)=O)=C3 |
InChiKey | PWHIUQBBGPGFFV-GOSISDBHSA-N |
InChi | InChI=1S/C22H25ClFN7O2/c1-13-10-26-22(28-17-2-4-33-5-3-17)30-20(13)31-11-19(27-12-31)21(32)29-18(9-25)14-6-15(23)8-16(24)7-14/h6-8,10-12,17-18H,2-5,9,25H2,1H3,(H,29,32)(H,26,28,30)/t18-/m1/s1 |
Cas号 | 2055597-12-9 |
相关CAS号 | 2055596-76-2 (racemic) 2055597-12-9 (free base) |
包装 | 价格 | 库存 | 纯度 | 备货期 |
---|---|---|---|---|
大货 | 询价 | 询价 | 询价 |
外观性状 | 固体粉末 |
---|---|
纯度 | ≧98.0% |
存储 | 短期(几天到几周)为0-4摄氏度,长期(几个月)为-20摄氏度 |
可溶性 | 可溶于DMSO |
处理方式 | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
运输条件 | 作为非危险化学品在环境温度下装运。这种产品在正常运输和海关工作期间可以稳定几周 |
海关编码 |
Targets | ERK inhibitor |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |